1. The comparison of transforming growth factor beta-1 serum levels in early-stage breast cancer patients treated with external beam whole breast irradiation plus boost versus interstitial brachytherapy accelerated partial breast irradiation
   Seyed Mohammad Hosseini et al, 2022, Brachytherapy CrossRef
2. Recent advances in targeted strategies for triple-negative breast cancer
   Shuangli Zhu et al, 2023, Journal of Hematology & Oncology CrossRef
3. Progress in Research on Tumor Metastasis Inhibitors
   Weiqi Xia et al, 2020, Current Medicinal Chemistry CrossRef
4. Glucocorticoid receptors are required effectors of TGFβ1-induced p38 MAPK signaling to advanced cancer phenotypes in triple-negative breast cancer
   Carlos Perez Kerkvliet et al, 2020, Breast Cancer Research CrossRef
5. TGF-β-Induced TMEPAI Promotes Epithelial–Mesenchymal Transition in Doxorubicin-Treated Triple-Negative Breast Cancer Cells via SMAD3 and PI3K/AKT Pathway Alteration
   Bantari WK Wardhani et al, 2021, Breast Cancer: Targets and Therapy CrossRef
6. TGF-β1 induced fascin1 expression facilitates the migration and invasion of kidney carcinoma cells through ERK and JNK signaling pathways
   Jianyu Yang et al, 2018, Biochemical and Biophysical Research Communications CrossRef
7. Stimulation of ATF3 interaction with Smad4 via TGF-β1 for matrix metalloproteinase 13 gene activation in human breast cancer cells
   M. Rohini et al, 2019, International Journal of Biological Macromolecules CrossRef
8. Gradient Rotating Magnetic Fields Impairing F-Actin-Related Gene CCDC150 to Inhibit Triple-Negative Breast Cancer Metastasis by Inactivating TGF-β1/SMAD3 Signaling Pathway
   Ge Zhang et al, 2024, Research CrossRef
9. Epigenetic regulation of triple negative breast cancer (TNBC) by TGF-β signaling
   Radhakrishnan Vishnubalaji et al, 2021, Scientific Reports CrossRef
10. A cytokine in turmoil: Transforming growth factor beta in cancer
    Alex Boye, 2021, Biomedicine & Pharmacotherapy CrossRef
11. MicroRNAs as Molecular Biomarkers for the Characterization of Basal-like Breast Tumor Subtype
    Muhammad Tariq et al, 2023, Biomedicines CrossRef
12. Prune-1 drives polarization of tumor-associated macrophages (TAMs) within the lung metastatic niche in triple-negative breast cancer
    Veronica Ferrucci et al, 2021, iScience CrossRef
13. TGFβ1 pathway components in breast cancer tissue from aggressive subtypes correlate with better prognostic parameters in ER-positive and p53-negative cancers
    Glauco Akelinghton Freire Vitiello et al, 2021, Surgical and Experimental Pathology CrossRef
14. New perspectives in triple-negative breast cancer therapy based on treatments with TGFβ1 siRNA and doxorubicin
    Cristina Alexandra Ciocan-Cȃrtiţă et al, 2020, Molecular and Cellular Biochemistry CrossRef
15. miR-145 inhibits proliferation and migration of breast cancer cells by directly or indirectly regulating TGF-β1 expression
    Yanling Ding et al, 2017, International Journal of Oncology CrossRef
16. At the Intersection of Cardiology and Oncology: TGFβ as a Clinically Translatable Therapy for TNBC Treatment and as a Major Regulator of Post-Chemotherapy Cardiomyopathy
    Andrew Sulaiman et al, 2022, Cancers CrossRef
17. Fibroblast growth factor‐2, derived from cancer‐associated fibroblasts, stimulates growth and progression of human breast cancer cells via FGFR1 signaling
    Jinyoung Suh et al, 2020, Molecular Carcinogenesis CrossRef
18. Multidimensional Molecular Profiling of Metastatic Triple-Negative Breast Cancer and Immune Checkpoint Inhibitor Benefit
    Romualdo Barroso-Sousa et al, 2022, JCO Precision Oncology CrossRef
19. Roles of TGF-β in cancer hallmarks and emerging onco-therapeutic design
    Xiaofeng Dai et al, 2022, Expert Reviews in Molecular Medicine CrossRef
20. Role of transforming growth factor-β1 in triple negative breast cancer patients
    Mingxia Zhang et al, 2017, International Journal of Surgery CrossRef
21. Progress in triple negative breast carcinoma pathophysiology: Potential therapeutic targets
    Kangjie Yu et al, 2020, Pathology - Research and Practice CrossRef
22. Clinically Translatable Approaches of Inhibiting TGF-β to Target Cancer Stem Cells in TNBC
    Andrew Sulaiman et al, 2021, Biomedicines CrossRef
23. Targeting CLK4 inhibits the metastasis and progression of breast cancer by inactivating TGF-β pathway
    Eunji Kang et al, 2022, Cancer Gene Therapy CrossRef
24. Toll-like receptor (TLR) gene expression and immunostimulatory effect of CpG oligonucleotides in hormone receptor positive cell line T47D and triple negative breast cancer cell line MDA-MB-468
    Sudhakar Natarajan et al, 2020, Immunopharmacology and Immunotoxicology CrossRef